Ailaaj
Dapa-Met XR 5/500mg tab 14-s

Hilton Pharma (Pvt) Ltd.

Dapa-Met XR 5/500mg tab 14-s

Dapaglifozin + Metformin 5/500 mg

SKU: 900224
Rs.610.96

Inclusive of all taxes · Pack of 14 Tab

One-time purchase — pay full price.
1
100% Genuine
Delivered in 1–3 working days
Easy returns

Frequently asked

  • Can I stop taking the medication when I feel better?

    For Dapa-Met XR 5/500 mg (dapagliflozin + metformin XR), you should not stop taking it just because you feel better unless your doctor advises you to. Type 2 diabetes is often a long-term condition, and feeling better usually means your blood glucose is being controlled—not necessarily that the diabetes has resolved. Stopping the medicine suddenly may cause your blood sugar levels to rise again and can increase the risk of diabetes-related complications.

Verified by Ailaaj Pharmacist

Licensed · DRAP-compliant

All products are sourced from DRAP-licensed suppliers and verified by our in-house pharmacists before dispatch.

View trust & licensing

Product overview

Product Summary:

Dapa-Met XR 5/500 mg tablet is an oral combination medicine containing dapagliflozin 5 mg and metformin extended-release 500 mg. It is used as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. The combination works by reducing glucose production in the liver (metformin) and increasing glucose removal through the urine (dapagliflozin).

Who It's For:

Adults with type 2 diabetes mellitus who need additional blood sugar control. Patients who may benefit from combination therapy when lifestyle changes or single-agent therapy are not providing adequate glycemic control. Individuals prescribed an SGLT2 inhibitor plus metformin regimen by a healthcare professional.

Key Benefits:

Helps lower and maintain blood glucose levels in type 2 diabetes. Provides dual action through two complementary mechanisms. May support improved HbA1c control when used as part of a diabetes management plan. Metformin component may help reduce excess glucose production by the liver. Dapagliflozin component may promote urinary glucose excretion and may provide additional cardiovascular and kidney-related benefits in appropriate patients as determined by a clinician.

Generic name
Dapaglifozin + Metformin 5/500 mg
Manufacturer
Hilton Pharma (Pvt) Ltd.
Form
Tablet
Pack size
Pack of 14 Tab
Prescription
Not required (OTC)
MRP
Rs.610.96

Uses

Primary Use:

Management of Type 2 diabetes mellitus to improve blood glucose control along with diet and exercise.

Also Used For:

As part of combination therapy when blood sugar targets are not achieved with lifestyle changes or other diabetes medicines. In selected patients, the dapagliflozin component may also be used for conditions such as heart failure or chronic kidney disease when specifically indicated by a healthcare professional.

Who May Benefit:

Adults with Type 2 diabetes who require additional glucose-lowering therapy. Patients needing a combination of metformin + SGLT2 inhibitor treatment. Individuals who need improved glycemic control as part of a comprehensive diabetes management plan.

Warnings & interactions

Warnings:

Use only as prescribed by a healthcare professional. Monitor kidney function before and during treatment, as metformin and dapagliflozin use depends on renal status. Risk of dehydration, low blood pressure, and increased urination due to dapagliflozin. Seek medical advice if symptoms of diabetic ketoacidosis occur (nausea, vomiting, abdominal pain, difficulty breathing, unusual tiredness). May increase the risk of genital or urinary tract infections. Inform your doctor before surgery, prolonged fasting, or severe illness, as temporary discontinuation may be required.

Avoid If:

Known allergy to dapagliflozin, metformin, or any ingredient in the tablet. Severe kidney impairment or certain cases of significant renal dysfunction. Metabolic acidosis or diabetic ketoacidosis. Severe dehydration or conditions causing reduced fluid intake. Type 1 diabetes (not indicated for routine use).

Interactions:

Diuretics (water pills): May increase the risk of dehydration and low blood pressure. Insulin or sulfonylureas: May increase the risk of low blood sugar (hypoglycemia). Alcohol (especially excessive use): May increase the risk of metformin-associated lactic acidosis. Iodinated contrast dyes used in imaging: May require temporary stopping of metformin in certain situations. Certain medicines affecting kidney function or blood glucose levels: May require monitoring or dose adjustment.

Common side effects

Nausea, stomach upset, or abdominal discomfort, Diarrhea or loose stools (especially when starting metformin), Increased urination, Thirst or dry mouth, Genital fungal infections (e.g., yeast infections) ,Urinary tract infections, Mild headache, Dizziness or feeling lightheaded

Generic & branded alternatives

Same category — verified equivalents you can switch to.